Similar articles

• [DDS for insulin--development of non-injection dosage forms].

  Murakami M, Muranishi S. Murakami M, et al. Nihon Rinsho. 1997 Nov;55 Suppl:273-81. Nihon Rinsho. 1997. PMID: 9434480 Review. Japanese. No abstract available.
• New strategies to improve the intranasal absorption of insulin.

  Duan X, Mao S. Duan X, et al. Drug Discov Today. 2010 Jun;15(11-12):416-27. doi: 10.1016/j.drudis.2010.03.011. Epub 2010 Mar 30. Drug Discov Today. 2010. PMID: 20359545 Review.
• [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].

  Yamamoto A. Yamamoto A. Nihon Rinsho. 1998 Mar;56(3):601-7. Nihon Rinsho. 1998. PMID: 9549343 Review. Japanese.
• On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs.

  Bae HD, Lee K. Bae HD, et al. J Control Release. 2013 Sep 28;170(3):358-64. doi: 10.1016/j.jconrel.2013.06.010. Epub 2013 Jun 18. J Control Release. 2013. PMID: 23791976
• [The design of oral insulin delivery systems based on smart hydrogels].

  Morishita M, Takayama K. Morishita M, et al. Nihon Rinsho. 2002 Sep;60 Suppl 9:516-21. Nihon Rinsho. 2002. PMID: 12387044 Review. Japanese. No abstract available.